【レポートの概要（一部）】
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top player positioning, 2017
3.4. Porter’s five forces analysis
3.5. Government regulations
3.6. Market dynamics
3.6.1. Drivers
3.6.1.1. Surge in R&D activities in healthcare
3.6.1.2. Rise in adoption of in vitro model
3.6.1.3. Increase in stringency of regulatory authorities concerning public healthcare welfare
3.6.1.4. Surge in adoption of early toxicity testing
3.6.2. Restraint
3.6.2.1. Limitations of preclinical testing
3.6.3. Opportunity
3.6.3.1. Technological advancement in the field of early toxicity testing
3.6.4. Impact analysis
CHAPTER 4: EARLY TOXICITY TESTING MARKET, BY TECHNIQUE
4.1. Overview
4.1.1. Market size and forecast
4.2. In Vivo
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. In Vitro
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.3.4. In vitro early toxicity testing market, by assay
4.3.4.1. Enzyme toxicity assays
4.3.4.1.1. Market size and forecast
4.3.4.2. Bacterial toxicity assays
4.3.4.2.1. Market size and forecast
4.3.4.3. Cell-based ELISA and western blots
4.3.4.3.1. Market size and forecast
4.3.4.4. Tissue culture assays
4.3.4.4.1. Market size and forecast
4.3.4.5. Receptor binding assays
4.3.4.5.1. Market size and forecast
4.3.4.6. Others
4.3.4.6.1. Market size and forecast
4.3.5. In vitro early toxicity testing market, by toxicity end-point
4.3.5.1. Dermal toxicity
4.3.5.1.1. Market size and forecast
4.3.5.2. Systemic toxicity
4.3.5.2.1. Market size and forecast
4.3.5.3. Carcinogenicity
4.3.5.3.1. Market size and forecast
4.3.5.4. Ocular toxicity
4.3.5.4.1. Market size and forecast
4.3.5.5. Skin sensitization and irritation
4.3.5.5.1. Market size and forecast
4.3.5.6. Genotoxicity
4.3.5.6.1. Market size and forecast
4.3.5.7. Neurotoxicity
4.3.5.7.1. Market size and forecast
4.3.5.8. Organ toxicity
4.3.5.8.1. Market size and forecast
4.3.5.9. Others
4.3.5.9.1. Market size and forecast
4.4. In silico
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: EUROPE EARLY TOXICITY TESTING MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Pharmaceutical industry
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Food industry
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Chemicals industry
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Cosmetic industry
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
5.6. Others
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country
CHAPTER 6: EARLY TOXICITY TESTING MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. early toxicity testing market, by technique type
6.2.2.1.2. U.S. early toxicity testing market, by end user
6.2.2.2. Canada
6.2.2.2.1. Canada early toxicity testing market, by technique type
6.2.2.2.2. Canada early toxicity testing market, by end user
6.2.2.3. Mexico
6.2.2.3.1. Mexico early toxicity testing market, by technique type
6.2.2.3.2. Mexico early toxicity testing market, by end user
6.2.3. Market size and forecast, by technique type
6.2.4. Market size and forecast, by end user
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country
6.3.2.1. Germany
6.3.2.1.1. Germany early toxicity testing market, by technique type
6.3.2.1.2. Germany early toxicity testing market, by end user
6.3.2.2. France
6.3.2.2.1. France early toxicity testing market, by technique type
6.3.2.2.2. France early toxicity testing market, by end user
6.3.2.3. UK
6.3.2.3.1. UK early toxicity testing market, by technique type
6.3.2.3.2. UK early toxicity testing market, by end user
6.3.2.4. Rest of Europe
6.3.2.4.1. Rest of Europe early toxicity testing market, by technique type
6.3.2.4.2. Rest of Europe early toxicity testing market, by end user
6.3.3. Market size and forecast, by technique type
6.3.4. Market size and forecast, by end user
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan early toxicity testing market, by technique type
6.4.2.1.2. Japan early toxicity testing market, by end user
6.4.2.2. China
6.4.2.2.1. China early toxicity testing market, by technique type
6.4.2.2.2. China early toxicity testing market, by end user
6.4.2.3. Australia
6.4.2.3.1. Australia early toxicity testing market, by technique type
6.4.2.3.2. Australia early toxicity testing market, by end user
6.4.2.4. India
6.4.2.4.1. India early toxicity testing market, by technique type
6.4.2.4.2. India early toxicity testing market, by end user
6.4.2.5. Rest of Asia-Pacific
6.4.2.5.1. Rest of Asia-Pacific early toxicity testing market, by technique type
6.4.2.5.2. Rest of Asia-Pacific early toxicity testing market, by end user
6.4.3. Market size and forecast, by technique type
6.4.4. Market size and forecast, by end user
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country
6.5.2.1. Brazil
6.5.2.1.1. Brazil early toxicity testing market, by technique type
6.5.2.1.2. Brazil early toxicity testing market, by end user
6.5.2.2. South Africa
6.5.2.2.1. South Africa early toxicity testing market, by technique type
6.5.2.2.2. South Africa early toxicity testing market, by end user
6.5.2.3. Rest of LAMEA
6.5.2.3.1. xx early toxicity testing market, by technique type
6.5.2.3.2. rest of LAMEA early toxicity testing market, by end user
6.5.3. Market size and forecast, by technique type
6.5.4. Market size and forecast, by end user
CHAPTER 7: COMPANY PROFILES
7.1. AGILENT TECHNOLOGIES, INC.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product type Portfolio
7.1.5. Business performance
7.2. BIOANALYTICAL SYSTEMS, INC.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. BRUKER CORPORATION
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.4. DANAHER CORPORATION (BECKMAN COULTER, INC.)
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product type portfolio
7.4.5. Business performance
7.5. EVOTEC AG (CYPROTEX)
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.6. ENZO BIOCHEM, INC. (ENZO CLINICAL LABS, INC.)
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product Portfolio
7.6.5. Business performance
7.7. GENERAL ELECTRIC COMPANY (GE HEALTHCARE)
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. MYRIAD GENETICS, INC. (MYRIAD RBM.)
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Product Portfolio
7.8.4. Business performance
7.9. PERKINELMER INC.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance
7.10. THERMO FISHER SCIENTIFIC, INC.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product Portfolio
7.10.5. Business performance
【レポート販売概要】
■ タイトル：早期毒性テストの世界市場：技術別（In Vivo、In Vitro、In Silico）、エンドユーザー別（製薬、食品、化学、化粧品、その他）■ 英文：Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), and End User (Pharmaceuticals Industry, Food Industry, Chemicals Industry, Cosmetics Industry, and Others): Global Opportunity Analysis and Industry Forecast, 2018–2025
■ 発行日：2019年5月10日
■ 調査会社：Allied Market Research
■ 商品コード：AMR9AG009
■ 調査対象地域：グローバル
- 心調律管理（CRM）医療装置のグローバル新興国市場（2012-2018）BRICSS Cardiac Rhythm Management Devices sector forecasts to reach at US$2.9 billion by 2016. China accounts for highest percentage approximately 26% (2015) of global share while India follows next with nearly 23% (2018) of the market. Forecasts for Cardiac Defibrillators indicate a close 54.5% of market share, while Cardiac Pacemakers Device is the fastest growing sector at a CAGR of 13.1% by 201 …
- 非常用ビーコン発信機の世界市場予測（～2020）The global emergency beacon transmitter market is expected to grow from USD 133.3 Million in 2015 to USD 175.4 Million by 2020, at a CAGR of 5.6% from 2015 to 2020. Emergency beacon transmitters are tracking devices that assist in the detection and location of boats, aircraft, and people in distress. When the transmitter is activated, the beacon emits a distress signal, and simultaneously the loca …
- スマートビルディングの世界市場：インテリジェントセキュリティシステム、エネルギー管理、インフラ管理The smart building market size is estimated to grow from USD 5.73 Billion in 2016 and to USD 24.73 Billion by 2021, at a CAGR of 34.0% from 2016 to 2021. Some of the major factors that are driving the growth of the market include the growing government initiatives for the development of smart building projects, rising focus on green buildings, and evolution of building management IoT platforms. Fu …
- 偽造防止包装技術の世界市場：改ざん防止包装、RFID、セキュリティラベル、追跡技術The rapid growth of world trade led by globalisation, coupled with the reduction of barriers to financial and merchandise flows, has certainly opened opportunities for counterfeit products. The sheer volume of imports in many countries makes it a challenging task for customs services to ban phony products. According to the World Customs Organisation, 7% of the total world trade is counterfeit, wor …
- Sarcoidosis：グローバル臨床試験レビューH2, 2013Sarcoidosis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Sarcoidosis Global Clinical Trials Review, H2, 2013" provides data on the Sarcoidosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sarcoidosis. It includes an overview of the trial numbers and their recruitment status as per the site of …
- Fallopian Tube Cancer：グローバル臨床試験レビューH2, 2013Fallopian Tube Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Fallopian Tube Cancer Global Clinical Trials Review, H2, 2013" provides data on the Fallopian Tube Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fallopian Tube Cancer. It includes an overview of the trial numbers and the …
- 紫外可視分光光度計の世界市場予測（～2021年）The UV/visible spectroscopy market is expected to reach USD 1,163.2 Million in 2021 from USD 944.2 Million in 2016, growing at a CAGR of 4.3%. The demand for UV/visible spectroscopy systems and accessories has been on the rise due to the rising application of this analytical technique in environmental testing. The growing application in pharmaceutical and biotechnology industries, rising need of f …
- ワクチンおよびワクチン接種の世界市場：インサイト、市場機会、市場シェア、市場予測The global vaccines & vaccination market is expected to grow at the CAGR of 10.5% during 2016-2022. The market has generated revenue of more than $ 467 million in 2016 and is projected to reach up to $ $769.4 million by 2022. Due to rising use of adjuvants in vaccine-preventable diseases, increasing government investments and initiatives, rising company investments in vaccine development and incre …
- 塩化鉄(III)の世界市場2015-2019About ferric chloride Ferric chloride is used as a coagulant, mostly in the form of a liquid (40% solution), in the treatment of wastewater and sewage water (domestic and industrial). Ferric chloride is also used in PCB manufacturing. Industrially, ferric chloride is much more important than ferrous chloride. It is produced industrially by a reaction of dry chlorine with scrap iron (direct chlorin …
- マラリア迅速診断装置の世界市場2019-2023About this market The growing incidence of malaria in countries has increased the need for malaria rapid diagnostic devices, which can provide rapid test results and can help in better diagnosis. The number of cases of malaria is higher in Africa and Southeast Asian countries because of poverty, the lack of healthcare infrastructure, and less knowledge about parasitic infectious diseases. The grow …
- Exelon Corporation：発電所及び企業SWTO分析2015Exelon Corporation - Power Plants and SWOT Analysis, 2015 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized and …
- ヨウ化エコチオフェートの世界市場Echothiophate Iodide (CAS 513-10-0) Market Research Report 2014 presents comprehensive data on echothiophate Iodide markets globally and regionally (Europe, Asia, North America etc.) The report includes echothiophate Iodide description, covers its application areas and related patterns. It overviews echothiophate Iodide market, names echothiophate Iodide producers and indicates its suppliers. Besi …
- 分散型電源の世界市場予測（～2022年）：太陽光発電、風力発電、レシプロエンジン、マイクロタービン、燃料電池、ガスタービンThe distributed generation market is projected to reach a market size of USD 60.04 Billion in 2017 and is expected to grow at a CAGR of 11.48% from 2017 to 2022. The growing demand for electric power accompanied with regulatory incentives for clean energy generation have shifted the focus toward distributed generation technologies. The report segments the distributed generation market, on the basi …
- Adenovirus Infections：グローバル臨床試験レビューH1, 2013Adenovirus Infections Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Adenovirus Infections Global Clinical Trials Review, H1, 2013" provides data on the Adenovirus Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Adenovirus Infections. It includes an overview of the trial numbers and the …
- 世界のワイン市場のニュース及びイベント動向（2014年6月）Synopsis The report provides a review of the latest news and key events in the global wine market during June 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global wine market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global wine market …
